GIS
VRTX icon

Graphene Investments SAS’s Vertex Pharmaceuticals VRTX Stock Holding History

Graphene Investments SAS’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Buy
7,500
+900
+14% +$399K 2.17% 14
2026
Q1 		$2.95M Sell
6,600
-900
-12% -$420K 1.98% 30
2025
Q4 		$3.4M Sell
7,500
-800
-10% -$345K 2.13% 18
2025
Q3 		$3.25M Buy
8,300
+1,500
+22% +$627K 2.06% 20
2025
Q2 		$3.03M Buy
6,800
+1,300
+24% +$599K 1.97% 25
2025
Q1 		$2.67M Sell
5,500
-1,000
-15% -$466K 1.95% 32
2024
Q4 		$2.62M Sell
6,500
-600
-8% -$278K 1.81% 41
2024
Q3 		$3.3M Hold
7,100
– – 2.12% 13
2024
Q2 		$3.33M Sell
7,100
-1,100
-13% -$477K 2.09% 17
2024
Q1 		$3.43M Hold
8,200
– – 2.07% 19
2023
Q4 		$3.34M Sell
8,200
-800
-9% -$296K 2.16% 6
2023
Q3 		$3.13M Hold
9,000
– – 2.2% 5
2023
Q2 		$3.17M Sell
9,000
-1,200
-12% -$404K 2.09% 16
2023
Q1 		$3.21M Buy
10,200
+600
+6% +$180K 2.15% 9
2022
Q4 		$2.77M Buy
+9,600
New +$2.93M 1.88% 36

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Graphene Investments SAS's VRTX Position: Q2 2026 in Review

Graphene Investments SAS increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, buying an estimated $399K and bringing the position to 7,500 shares worth $3.73M. The position accounts for 2.17% of the portfolio, ranked #14.

Graphene Investments SAS first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. 436 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Graphene Investments SAS held 7,500 shares of Vertex Pharmaceuticals worth $3.73M as of Q2 2026.
  • Graphene Investments SAS bought 900 Vertex Pharmaceuticals shares in Q2 2026, an estimated $399K.
  • Vertex Pharmaceuticals made up 2.17% of Graphene Investments SAS's portfolio in Q2 2026, its #14 holding.
  • Graphene Investments SAS first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 436 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Graphene Investments SAS's 13F filing for Q2 2026, filed 20 Jul 2026.